Researchers
Our research is structured into research themes, programs of work and teams. We are committed to collaboration and to work together.
Research theme leaders
BA (Education) PhD Candidate
Director of First Nations Strategy and Leadership; Head, First Nations Health and Equity Research
BSc PhD
Head, Chronic Diseases Research
OAM BSc (Hons) GradDipClinEpi PhD
BSc (Hons) PhD
Theme Head, Wellbeing and Mental Health
BSc (Hons) MSc PhD
Feilman Fellow; Head, Precision Health Research and Head, Translational Intelligence
BMedSci (hons), PhD
Shaping excellence
Rewarding excellence
Learn more about how The Kids rewards research excellence
Learn more about how The Kids rewards research excellenceResearch governance
We pride ourselves on conducting research to the highest standards possible
Find out more about research governanceCurrent career opportunities
Want to join our team and help make a difference to child health?
Learn more about Current career opportunitiesHelp shape our research
Find out how you can involve consumers and the community in your research
Help shape our researchReports & findings
Chlorinated drinking water exposure enriches antimicrobial resistance pathways in the infant gut microbiome: a randomized trial
Water chlorination is essential for controlling harmful microbes in drinking water; however, the antimicrobial effects of chlorine-based disinfectants present in tap water may influence early-life gut microbial ecology.
Acceptability and Utility of a Virtual Reality Diabetes-Related Foot Disease Training Program for First Nations People: A Pragmatic Quasi-Experimental Case Series Study
To test the utility and acceptability of a novel VR training tool for community health practitioners in assessing diabetes-related foot disease in Aboriginal and Torres Strait Islander people.
Platform trial in COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity and safety of seven licensed COVID-19 vaccines delivered as fifth dose or subsequent boosters
PICOBOO is a randomised, adaptive trial evaluating the immunogenicity and reactogenicity of licensed COVID-19 booster vaccines in immunocompetent individuals >12 years old. Here, we present data for seven different vaccines among three pre-specified participant strata defined by age and primary vaccine schedule.
FEF25–75% trajectories from age 7 to 53 years, associations with childhood and parental preconception factors, and midlife COPD risk: a prospective cohort study
Existing trajectory studies have emphasised large-airway indices, but chronic obstructive pulmonary disease (COPD) might originate in smaller airways. This study aimed to investigate mid-to-small-airway function trajectories, their associated factors, and COPD risk.